Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB. Pachychoroid disease. Eye. 2019;33:14–33.
Dansingani KK, Balaratnasingam C, Naysan J, Freund KB. En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina. 2016;36:499–516.
Balaratnasingam C, Lee WK, Koizumi H, Dansingani K, Inoue M, Freund KB. Polypoidalchoroidalvasculopathy: a distinct disease or manifestation of many? Retina. 2016;36:1–8.
Ijuin N, Tsujinaka H, Hirai H, Jimura H, Nakao S, Yamashita M, et al. Clinical implications of pachyvessels in polypoidalchoroidalvasculopathy. BMC Ophthalmol. 2020;20:170.
Lee WK, Baek J, Dansingani KK, Lee JH, Freund KB. Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal subfoveal choroidal thickness. Retina. 2016;36:S73–S82.
Pang CE, Shah VP, Sarraf D, Freund KB. Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy. Am J Ophthalmol. 2014;158:362–71.e2.
Jung JJ, Yu DJG, Ito K, Rofagha S, Lee SS, Hoang QV. Quantitative assessment of asymmetric choroidal outflow in pachychoroid eyes on ultra-widefieldindocyanine green angiography. Invest Ophthalmol Vis Sci. 2020;61:50.
Lee A, Ra H, Baek J. Choroidal vascular densities of macular disease on ultra-widefieldindocyanine green angiography. Graefes Arch Clin Exp Ophthalmol. 2020;258:1921–9.
Chung SE, Kang SW, Kim JH, Kim YT, Park DY. Engorgement of vortex vein and polypoidalchoroidalvasculopathy. Retina. 2013;33:834–40.
Spaide RF. Choroidal blood flow: review and potential explanation for the choroidal venous anatomy including the vortex vein system. Retina. 2020;40:1851–64.
Kutoglu T, Yalcin B, Kocabiyik N, Ozan H. Vortex veins: anatomic investigations on human eyes. Clin Anat. 2005;18:269–73.
Lim MC, Bateman JB, Glasgow BJ. Vortex vein exit sites. Scleral coordinates. Ophthalmology. 1995;102:942–6.
Hayreh SS, Baines JA. Occlusion of the vortex veins. An experimental study. Br J Ophthalmol. 1973;57:217–38.
Hiroe T, Kishi S. Dilatation of asymmetric vortex vein in central serous chorioretinopathy. Ophthalmol Retin 2018;2:152–61.
Matsumoto H, Kishi S, Mukai R, Akiyama H. Remodeling of macular vortex veins in pachychoroidneovasculopathy. Sci Rep. 2019;9:14689.
Matsumoto H, Hoshino J, Mukai R, Nakamura K, Kikuchi Y, Kishi S, et al. Vortex vein anastomosis at the watershed in pachychoroid spectrum diseases. Ophthalmol Retina. 2020;4(Sep):938–45.
Spaide RF, Ledesma-Gil G, Gemmy Cheung CM. Intervortex venous anastomosis in pachychoroid-related disorders. Retina. 2020. https://doi.org/10.1097/IAE.0000000000003004. [Epub ahead of print].
Matsumoto H, Hoshino J, Arai Y, Mukai R, Nakamura K, Kikuchi Y, et al. Quantitative measures of vortex veins in the posterior pole in eyes with pachychoroid spectrum diseases. Sci Rep. 2020;10:19505.
Acknowledgements
BDK acknowledges an unrestricted grant from Research to Prevent Blindness to the Gavin Herbert Eye Institute at the University of California, Irvine. UC has received grants from the National Institute for Health Research and Novartis
Author information
Authors and Affiliations
Contributions
Contributors AS: conception, analysis, drafting, integrity check, final approval. NP, NK, FB, BDK, AL, CR, UC: drafting, revision, analysis, integrity check.
Corresponding author
Ethics declarations
Conflict of interest
AS—consultant: Novartis India, Allergan Global, Intas India, Bayer India. NP: none. NK: none. FB—consultant: Allergan, Bayer, BoehringerIngelheim, FidiaSooft, Hoffmann-La Roche, Novartis, NTC Pharma, Sifi, ThromboGenics, Zeiss. BDK—clinical research: Alcon, Alimera, Allegro, Allergan, Apellis, Clearside, Genentech, GSK, Ionis, jCyte, Novartis, Regeneron, ThromboGenics; consultant: Alimera, Allegro, Allergan, Cell Care, Dose, Eyedaptic, Galimedix, Genentech, Glaukos, Interface Biologics, jCyte, Novartis, Ophthotech, Regeneron, Revana, TheravanceBiopharma, AL—consultant: Allergan, Novartis, Roche, Notal Vision, FiorSightsLabs, Beyeonics, Bayer Healthcare. CR—consultant: Allergan, Chengdu Kanghong, Genentech/Roche, Novartis, Kodiak, Notal, Merck, Shire-Takeda, Adverum, Graybug, Eyepoint; research support: Allergan, Chengdu Kanghong, Genentech/Roche, Novartis, Kodiak, Iveric, Adverum. UC—personal fees from Allergan, Bayer, Novartis, and Roche; and is a data safety and monitoring board member for Bayer.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sharma, A., Parachuri, N., Kumar, N. et al. Vortex vein anastomosis and pachychoroid—an evolving understanding. Eye 35, 1545–1547 (2021). https://doi.org/10.1038/s41433-021-01423-2
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-021-01423-2
This article is cited by
-
Pro re nata anti-VEGF treatment in pachychoroid neovasculopathy compared with age-related macular degeneration based on optical coherence tomography
International Ophthalmology (2024)
-
InCASEOf scoring system for distinction between pachychoroid-associated macular neovascularization and neovascular age-related macular degeneration in patients older than 50 years
Scientific Reports (2022)